Article information
Abstract
Lichen sclerosus is a chronic inflammatory mucocutaneous disease that is highly bothersome for men and women of all ages. The exact etiology is unknown, although genetic and autoimmune factors, as well as infections, have been implicated in its pathogenesis. Firstline treatment is highly potent topical corticosteroid therapy for short periods. Surgery is reserved for cases of phimosis, urethral stenosis, synechiae, and squamous cell carcinoma.
Key words:
Lichen sclerosus
Lichen sclerosus et atrophicus
Review
Resumen
El liquen escleroso es una enfermedad inflamatoria crónica mucocutánea que causa una gran molestia en hombres y mujeres de todas las edades. La etiología exacta es desconocida, aunque factores genéticos, autoinmunitarios e infecciosos se han implicado en su patogénesis. El tratamiento de primera línea es la corticoterapia ultrapotente tópica durante un tiempo limitado, y se reserva la cirugía en caso de fimosis, estenosis uretral, sinequias y carcinoma escamoso.
Palabras clave:
liquen escleroso
liquen escleroso y atrófico
revisión
Full text is only aviable in PDF
References
[1.]
H. Hallopeau.
Du lichen plan et particulièrement de sa forme atrophique: lichen plan scléreux.
Ann Dermatol Syphiligr (Paris), 8 (1887), pp. 790-791
[2.]
J. Darier.
Lichen plan scléreux.
Ann Dermatol Syphiligr (Paris), 23 (1892), pp. 833-837
[3.]
H.J. Wallace.
Lichen sclerosus et atrophicus.
Trans St John's Dermatol Soc (England), 57 (1971), pp. 9-30
[4.]
A. Guerra.
Liquen escleroso.
Actas Dermosifiliogr, 94 (2003), pp. 633-641
[5.]
E.E. Sahn, E.L. Bluestein, S. Oliva.
Familial lichen sclerosus et atrophicus in childhood.
Pediatr Dermatol, 11 (1994), pp. 160-163
[6.]
J.M. Pugliese, A.F. Morey, A.C. Peterson.
Lichen sclerosus: Review of the literature and current recommendations for management.
J Urol, 178 (2007), pp. 2268-2276
[7.]
A. Kiss, L. Kiraly, B. Kutasy, M. Merksz.
High incidence of balanitis xerotica obliterans in boys with phimosis: Prospective 10-year study.
Pediatr Dermatol, 22 (2005), pp. 305-308
[9.]
I. Depasquale, A.J. Park, A. Bracka.
The treatment of balanitis xerotica obliterans.
BJU Int, 86 (2000), pp. 459-465
[10.]
S.L. Fleet, L.S. Davis.
Infantile perianal pyramidal protrusion: Report of a case and review of the literature.
Pediatr Dermatol, 22 (2005), pp. 151-152
[11.]
M.J. Cruces, C. De La Torre, A. Losada, C. Ocampo, I. García-Doval.
Infantile pyramidal protrusion as a manifestation of lichen sclerosus et atrophicus.
Arch Dermatol, 134 (1998), pp. 1118-1120
[12.]
K. Kayashima, M. Kitoh, T. Ono.
Infantile perianal pyramidal protrusion.
Arch Dermatol, 132 (1996), pp. 1481-1484
[13.]
Y. Jiménez, C. Gavaldá, E. Carbonell, M. Margaix, G. Sarrion.
Lichen sclerosus of the oral mucosa: A case report.
Med Oral Patol Oral Cir Bucal, 13 (2008), pp. 403-406
[14.]
V. Madan, N.H. Cox.
Extensive bullous lichen sclerosus with scarring alopecia.
Clin Exp Dermatol, 34 (2008), pp. 360-362
[15.]
J. Powell, F. Wojnarowska, S. Winsey.
Lichen sclerosus premenarche: Autoimmunity and immunogenetics.
Br J Dermatol, 142 (2000), pp. 481-484
[16.]
S.K. Goolamali, E.W. Barnes, W.J.K. Irvine, S. Shuster.
Organ-specific antibodies in patients with lichen sclerosus.
BMJ, 4 (1974), pp. 78-79
[17.]
C.I. Harrington, I.R. Dunsmore.
An investigation into the incidence of auto-immune disorders in patients with lichen sclerosus and atrophicus.
Br J Dermatol, 104 (1981), pp. 563
[18.]
P. Marren, J. Yell, F.M. Charnock, M. Bunce, K. Welsh, F. Wojnarowska.
The association between lichen sclerosus and antigens of the HLA system.
Br J Dermatol, 132 (1995), pp. 197-203
[19.]
R.H. Meyrick, C.M. Ridley, D.H. McGibbon, M.M. Black.
Lichen sclerosus et atrophicus and autoimmunity - a study of 350 women.
Br J Dermatol, 118 (1988), pp. 41-46
[20.]
R.H. Meyrick, C.M. Ridley, M.M. Black.
The association of lichen sclerosus et atrophicus and autoimmune-related disease in males.
Br J Dermatol, 109 (1983), pp. 661-664
[21.]
R.M. Azurdia, G.A. Luzzi, I. Byren, K. Welsh, F. Wojnarowska, P. Marren, et al.
Lichen sclerosus in adult men: A study of HLA association and susceptibility to autoimmune disease.
Br J Dermatol, 140 (1999), pp. 79-83
[22.]
O. Noritaka, I. Chan, S.M. Nell, T. Hamada, A.P. South, V. Wessagowit, et al.
Autoantibodies to extracellular matrix protein 1 in lichen sclerosus.
Lancet, 362 (2003), pp. 118-123
[23.]
D. Jorda, D. Ramón, A. Galan, V. Torres, Z. Zayas, J.M. Verdeguer, et al.
Liquen escleroatrófico cutáneo familiar: presentación a lo largo de tres generaciones.
Actas Dermosifiliogr, 82 (1991), pp. 470-472
[24.]
R.H. Meyrick, C.T. Kennedy.
The development of lichen sclerosus et atrophicis in monozygotic twin girls.
Br J Dermatol, 108 (1986), pp. 41-46
[25.]
N.H. Cox, J.N. Mitchell, W.N. Morley.
Lichen sclerosus et atrophicus in non-identical female-twins.
Br J Dermatol, 115 (1986), pp. 743-746
[26.]
F.E. Clay, M.J. Cork, J.K. Tarlow, A.I. Blakemore, C.I. Harrington, F. Lewvis, et al.
Interleukin 1 receptor antagonist gene polymorphism association with lichen sclerosus.
Hum Genet, 94 (1994), pp. 407-410
[27.]
E.G. Friedrich, P.S. Kalra.
Serum levels of sex hormones in vulvar lichen sclerosus and the effect of topical testosterone.
N Engl J Med, 310 (1984), pp. 488-491
[28.]
E. Edmonds, S. Mavin, N. Francis, D. Ho-Yen, C. Bunker.
Borrelia burgdorferi is not associated with lichen sclerosus in men.
Br J Dermatol, 160 (2009), pp. 450-460
[29.]
P. Ena, P. Lorrai, A. Pintus, V. Marras, L.A. Dessy.
Development of multifocal squamous cell carcinoma in lichen sclerosus et atrophicus of the penis associated to HCV hepatitis.
Andrologia, 36 (2004), pp. 38-40
[30.]
R. Vignale, G. Acosta, J. Paciel, V. González.
Presencia del virus del papiloma humano en lesiones del liquen escleroso y atrófico vulvar. Estudio por inmunohistoquímica e hibridación in situ.
Actas Dermosifiliogr, 93 (2002), pp. 389-392
[31.]
M. Karram, B. Tabor, D. Smotkin, F. Wettstein, N. Bhatia, J. Micha.
Detection of human papillomavirus deoxyribonucleic acid from vulvar dystrophies and vulvar intraepithelial neoplastic lesions.
Am J Obstet Gynecol, 159 (1988), pp. 22-23
[32.]
S.M. Neil, M. Leibowitch, M.E. Pelisse.
Lichen sclerosus, invasive squamous cell carcinoma, and human papillomavirus.
Am J Obstet Gynecol, 162 (1990), pp. 1633-1634
[33.]
P. Kiene, K. Mild-Langosh, T. Löning.
Human papillomavirus infection in vulvar lesions of lichen sclerosus et atrophicus.
Arch Dermatol, 282 (1991), pp. 445-448
[34.]
S. Simpkin, A. Oakley.
Clinical review of 202 patients with vulvar lichen sclerosus: A possible association with psoriasis.
Australas J Dermatol, 48 (2007), pp. 28-31
[35.]
B. Eberz, A. Berghol, S. Regauer.
High prevalence of concomitant anogenital lichen sclerosus and extragenital psoriasis in adult women.
Obstet Gynecol, 111 (2008), pp. 1143-1147
[36.]
B. García Bravo, P. Sánchez, A. Rodríguez Pichardo, F. Camacho.
Lichen sclerosus et atrophicus. A study of 76 cases and their relation to diabetes.
J Am Acad Dermatol, 19 (1988), pp. 482-485
[37.]
M.A. Fung, P.E. Leboit.
Light microscopic criteria for the diagnosis of early vulvar lichen sclerosis: A comparison with lichen planus.
Am J Surg Pathol, 22 (1998), pp. 473-478
[38.]
A.M. Farrell, D. Dean, P.R. Millard, F.M. Charnock, F. Wojnarowska.
Alterations in fibrillin as well collagens I and III and elastin occur in vulval lichen sclerosus.
J Eur Acad Dermatol Venereol, 15 (2001), pp. 212-217
[39.]
I. Val, G. Almeida.
An overview of lichen sclerosus.
Clin Obstet Gynecol, 48 (2005), pp. 808-817
[40.]
G. Barbagli, E. Palminteri, F. Mirri, et al.
Penile carcinoma in patients with genital lichen sclerosus: a multicenter survey.
J Urol, 175 (2006), pp. 1359-1363
[41.]
P.D. Yesudian, H. Sugunendran, C.M. Bates, C. O’Mahony.
Lichen sclerosus.
Int J STD AIDS, 16 (2005), pp. 465-473
[42.]
G. Poindexter, D.S. Morrell.
Anogenital pruritus: Lichen sclerosus in children.
Pediatr Ann, 36 (2007), pp. 785-791
[43.]
M.L. Maroon, N.B. Esterly.
Constipation as a feature of anogenital lichen sclerosus in children.
Pediatrics, 115 (2005), pp. 230-232
[44.]
S.J. Young, D.L. Wells, E.J. Ogden.
Lichen sclerosus, genital trauma and child sexual abuse.
Aust Fam Physician, 22 (1993), pp. 732-733
[45.]
J. Powell, F. Wojnarowska.
Childhood vulvar lichen sclerosus and sexual abuse are not mutually exclusive diagnoses.
BMJ, 320 (2000), pp. 311
[46.]
R. Isaac, M. Lyn, N. Triggs.
Lichen sclerosus in the differential diagnosis of suspected child abuse cases.
Pediat Emerg Care, 23 (2007), pp. 482-485
[47.]
S.A. Warrington, C. De San Lázaro.
Lichen sclerosus et atrophicus and sexual abuse.
Arch Dis Child, 75 (1996), pp. 512-516
[48.]
S.M. Neil, C.M. Ridley.
Management of anogenital lichen sclerosus.
Clin Exp Dermat, 26 (2001), pp. 637-643
[49.]
U.R. Hengge, W. Krause, H. Hoffman, R. Stadler, G. Gross, M. Meurer, et al.
Multicentre, phase II trial on the safety and efficacy of topical tacrolimus ointment for the treatment of lichen sclerosus.
Br J Dermatol, 155 (2006), pp. 1021-1028
[50.]
K. Edey, D. Bisson, C. Kennedy.
Topical tacrolimus in the management of lichen sclerosus.
BJOG, 113 (2006), pp. 1482
[51.]
R. Nissi, H. Eriksen, J. Risteli, et al.
Pimecrolimus cream 1% in the treatment of lichen sclerosus.
Gynecol Obstet Invest, 63 (2007), pp. 151-154
[52.]
F.M. Lewis, S.M. Neill.
Safety of calcineurin inhibitors in the management of lichen sclerosus.
Br J Dermatol, 156 (2007), pp. 1389-1390
[53.]
P. Merren, F. Wojnarowski, S. Powell.
Allergic contact dermatitis and vulvar dermatoses.
Br J Dermatol, 126 (1992), pp. 52-56
[54.]
M. Sideri, M. Orgioni, L. Spinaci, A. Ferrari.
Topical testosterone in the treatment of vulvar lichen sclerosus.
Int J Gynecol Obstet, 46 (1994), pp. 53-56
[55.]
S. Gupta, A. Saraswat, B. Kumar.
Treatment of genital lichen sclerosus with topical calcipotriol.
Int J STD AIDS, 16 (2005), pp. 772-774
[56.]
C.M. Peterson, J.E. Kane, J.L. Ratz.
Successful carbon dioxide laser therapy for refractory anogenital lichen sclerosus.
Dermatol Surg, 30 (2004), pp. 1148-1151
[57.]
T. Windahl.
Is carbon dioxide laser treatment of lichen sclerosus effective in the long run?.
Scand J Urol Nephrol, 40 (2006), pp. 208-211
[58.]
M. Kartamaa, S. Reitamo.
Treatment of lichen sclerosus with carbon dioxide laser vaporisation.
Br J Dermatol, 136 (1997), pp. 356-359
[59.]
P.J. August, T.M. Milward.
Cryosurgery in the treatment of lichen sclerosus et atrophicus.
Br J Dermatol, 103 (1980), pp. 667-670
[60.]
P. Hillemans, M. Untch, F. Prove, et al.
Photodynamic therapy of vulvar lichen sclerosus with 5-aminolevulinic acid.
Obstet Gyneco, 93 (1999), pp. 71-74
[61.]
P.E. Beattie, R.S. Dawe, J. Ferguson, S.H. Ibbotson.
UVA1 phototherapy for genital lichen sclerosus.
Clin Exp Dermatol, 31 (2006), pp. 343-347
[62.]
J. Dalmau, E. Baselga, E. Roé, A. Alomar.
Psoralen-UVA treatment for generalized prepubertal extragenital lichen sclerosus et atrophicus.
J Am Acad Dermatol, 55 (2006), pp. 56-58
[63.]
P.Y. Basak, K. Basak.
Lichen sclerosus et atrophicus of the scalp: Satisfactory response to acitretin.
J Eur Acad Dermatol Venereol, 16 (2002), pp. 183-185
[64.]
M.T. Bousema, U. Romppanem, J.M. Geiger, M. Baudin, K. Vähä-Eskeli, J. Vartiainen, et al.
Acitretin in the treatment of severe lichen sclerosus et atrophicus of the vulva: A double-blind, placebo-controlled study.
J Am Acad Dermatol, 20 (1994), pp. 225-231
Copyright © 2010. Academia Española de Dermatología y Venereología and Elsevier España, S.L.
